Clinical Trial Update: Safety and Efficacy of Atezolizumab-Bevacizumab Versus Tyrosin Kinase Inhibitors in Patients With Liver Cirrhosis

View source ↗

Summary

A completed clinical trial assesses safety and efficacy of the atezolizumab‑bevacizumab combination versus tyrosine kinase inhibitors in patients with hepatocel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• Tyrosine kinase inhibitors

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Hepatocellular Carcinoma, Liver Cirrhosis | Status: COMPLETED